Skip to Content

Magnesium glycinate Disease Interactions

There are 2 disease interactions with magnesium glycinate:

Major

Magnesium salts (applies to magnesium glycinate) renal dysfunction

Major Potential Hazard, Moderate plausibility.

Magnesium is eliminated by the kidney. The serum concentration of magnesium is increased in patients with renal impairment. Magnesium toxicity includes CNS depression, muscular paralysis, respiratory depression, hypotension and prolonged cardiac conduction time. Disappearance of the patellar reflex is a useful clinical sign of magnesium intoxication. Therapy with magnesium should be administered cautiously and dosages should be modified in patients with compromised renal function. Clinical monitoring of serum magnesium levels is recommended.

References

  1. "Product Information. Mag-Ox 400 (magnesium oxide)." Blaine, Erlanger, KY.
  2. "Product Information. Losospan (magaldrate)." Whitehall-Robbins, Madison, NJ.
  3. "Product Information. Slow-Mag (magnesium chloride)." Searle, Skokie, IL.
  4. "Product Information. Magonate (magnesium gluconate)." Fleming and Company, Fenton, MO.
  5. "Product Information. Uro-Mag (magnesium oxide)." Blaine, Erlanger, KY.
View all 5 references
Moderate

Magnesium glycinate sugar/alcohol

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Diabetes Mellitus, Liver Disease, Alcoholism, Phenylketonuria

Liquids, powders, and some other forms of magnesium glycinate may contain sugar and/or aspartame. Liquid products may also contain alcohol. Caution is advised in patients that have diabetes, alcohol dependence, liver disease, phenylketonuria (PKU), or any other condition that requires to limit or avoid these substances.

Magnesium glycinate drug interactions

There are 46 drug interactions with magnesium glycinate

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.